Table 1.
Characteristics of patients (N = 48).
| Age, median (range) | 59 (31, 81) |
| Sex (N, %) | |
| Female | 24 (50) |
| Male | 24 (50) |
| ECOG performance status, (N, %) | |
| 0 | 11 (23) |
| 1 | 30 (62) |
| 2 | 7 (15) |
| Race (N, %) | |
| White | 36 (75) |
| Black or African American | 9 (19) |
| Asian | 3 (6) |
| Ethnicity | |
| Hispanic or Latino | 6 (12) |
| Non-Hispanic | 42 (88) |
| Primary cancer type (N, %) | |
| Neuroendocrine tumour | 5 (11) |
| Colon cancer | 6 (13) |
| Pancreatic cancer | 6 (13) |
| Ovarian cancer | 6 (13) |
| Epithelioid hemangioendothelioma | 2 (4) |
| Melanoma | 2 (4) |
| Breast cancer | 3 (6) |
| Leiomyosarcoma | 2 (4) |
| Adamantinoma | 1 (2) |
| Parotid cancer | 1 (2) |
| Nasopharyngeal carcinoma | 1 (2) |
| Squamous cell cancer of tongue | 1 (2) |
| Endometrial cancer | 1 (2) |
| Cholangiocarcinoma | 2 (4) |
| Hepatocellular carcinoma | 2 (4) |
| Basal cell carcinoma | 1 (2) |
| Soft tissue sarcoma | 3 (6) |
| Lung cancer | 2 (4) |
| Prostate cancer | 1 (2) |
| Prior chemotherapy regimens (N, %) | |
| >3 | 38 (79) |
| <3 | 10 (21) |